Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)
Funding Opportunity PAR-23-277 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NCI R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this Notice of Funding Opportunity (NOFO) will support creative educational activities with a primary focus on Research Experiences. Applications are encouraged that propose innova...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 21, 2023 Category: Research Source Type: funding
Request for Information (RFI): Identifying Opportunities to Generate Research Molecular Characterization Data for the Childhood Cancer Data Initiative (CCDI)
Notice NOT-CA-23-093 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 20, 2023 Category: Research Source Type: funding
Notice of Pre-Application Webinar for PAR-23-244: Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
Notice NOT-CA-23-091 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 12, 2023 Category: Research Source Type: funding
NIH All About Grants Podcast: What Early Career Researchers Should Know (Part 1) – the Hidden Curriculum
Dr. Lauren Ullrich, co-host of Building Up the Nerve from the National Institute of Neurological Disorders and Stroke
Dr. Oliver Bogler, host of Inside Cancer Careers from the National Cancer Institute
Embarking on a career in biomedicine is more than doing experiments and writing NIH grant applications. How does one learn about other important skills early in their research career, and what exactly are they?
This episode of a two-part NIH All About Grants Podcast mini-series explores the “hidden curriculum” for early career researchers. Our conversation features hosts of two NIH podcasts that delve into topics ...
Source: NIH Extramural Nexus - September 8, 2023 Category: Research Authors: NIH Staff Tags: New Resources mentorship podcast workforce Source Type: funding
Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional)
Funding Opportunity PAR-23-292 from the NIH Guide for Grants and Contracts. Through this notice of funding opportunity (NOFO), the National Cancer Institute (NCI) intends to support the rigorous assessment of barriers to quality cancer treatment and follow-up care for sexual and gender minority (SGM) cancer survivors. The NCI solicits proposals for observational and/or interventional studies of SGM survivors designed to understand barriers and/or improve care and outcomes for SGM people with cancer, using interoperable sexual orientation and gender identity (SOGI) data collection in cancer care settings. (Source: NIH Fu...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 7, 2023 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Mechanisms Driving Obesity and Prostate Cancer Risk
Notice NOT-CA-23-089 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 30, 2023 Category: Research Source Type: funding
Single Source: Pediatric Early Phase Clinical Trials Network (PEP-CTN; UM1 Clinical Trial Required)
Funding Opportunity RFA-CA-24-007 from the NIH Guide for Grants and Contracts. Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to enhance NCIs program for conducting early phase clinical trials in children with cancer, thereby facilitating the introduction of high priority novel agents into the pediatric oncology setting in a timely manner. This ability to quickly conduct first in children studies is critical to NCIs overall clinical research program for children with cancer. The primary scope of the Pediatric Early Phase Clinical Trials Network (PEP-CTN) is to design and c...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 25, 2023 Category: Research Source Type: funding
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-23-280 from the NIH Guide for Grants and Contracts. The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (including agonists or antagonists of GLP-1, GIP-1, or dual GLP-1/GIP-1 agents) impact cancer risk, and to draw talented scientists who understand the dynamic changes caused by these agents to investigate the mechanisms of how these agents influence cancer risk rather than shorter term outcomes such as weight loss and diabetes. The data thus far suggests that these agents may increa...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 24, 2023 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for Pre-Cancer Atlas (PCA) Research Centers (U01 Clinical Trial Not Allowed)
Notice NOT-CA-23-085 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 24, 2023 Category: Research Source Type: funding
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
Funding Opportunity PAR-23-279 from the NIH Guide for Grants and Contracts. The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (including agonists or antagonists of GLP-1, GIP-1, or dual GLP-1/GIP-1 agents) impact cancer risk, and to draw talented scientists who understand the dynamic changes caused by these agents to investigate the mechanisms of how these agents influence cancer risk rather than shorter term outcomes such as weight loss and diabetes. The data thus far suggests that these agents may increa...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 23, 2023 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity for The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12 Clinical Trial Optional)
Notice NOT-CA-23-081 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 23, 2023 Category: Research Source Type: funding
Chimeric Antigen Receptor (CAR) Approaches to AD/ADRD (R61/R33 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-24-046 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) aims toprovide a proof-of-principle for a novel strategy for Alzheimer Disease and Alzheimer Related Dementias (AD/ADRD) immunotherapies. Specifically, the goal is to examine if a novel immunotherapeutic approach in cancer immunotherapy with Chimeric Antigen Receptor (CAR) immune cellscould be customized as treatments for AD/ADRD. This NOFO utilizes the R61/R33Exploratory/Developmental Phased Award activity code. The R61 phase provides up to 2 years of support for initial developmental activities. The...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 23, 2023 Category: Research Source Type: funding
Tennessee Breast and Cervical Screening Program (TBCSP) Evidence-Based Interventions
Funding to increase breast and cervical cancer screening with a focus on populations who are underserved and who have increased cancer risk due to inequities. Geographic coverage: Tennessee -- Tennessee Department of Health (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - August 22, 2023 Category: American Health Source Type: funding
Indigenous Pink Champions Micro-Grants
Micro-grants for tribal clinics to host an Indigenous Pink event during the month of October. Events should raise awareness of breast cancer, which is the most common cancer among native women and the second leading cause of cancer death. Geographic coverage: Nationwide -- American Indian Cancer Foundation (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - August 21, 2023 Category: American Health Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional)
Notice NOT-CA-23-084 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 21, 2023 Category: Research Source Type: funding
